" Our results have indicated that by using a combination of immune-checkpoint inhibition and gold nanostar (GNS)-mediated photothermal therapy, it is possible to achieve complete eradication of primary treated tumors as well as distant untreated tumors tumors and induce long-term anti-cancer immunity in mice implanted with the MB49 bladder cancer cell line. " The war on cancer was declared almost half a century ago and yet the incidence of cancer is decreasing for only a handful of cancer types and most cancers that have spread beyond their organ of origin remain incurable. In fact, cancer is the most common cause of death in people aged less than 85 years and it is estimated that in 2012 there were more than 14.1 million new cancer cases worldwide and 8.2 million deaths that resulted [1].Nanomedicine has contributed to important advances in healthcare over the past few decades. In particular, the use of nanoparticles in medicine has attracted increased attention for their unique efficacy and specificity in therapy [2]. One exciting new development is nanoparticle-mediated thermal therapy which has demonstrated the potential for precise tumor cell ablation [3], radio-sensitization of hypoxic regions [4], enhancement of drug delivery [5], activation of thermosensitive agents [6] and enhancement of the immune system [7]. A special type of metallic nanoparticles, called 'plasmonic' nanoparticles, has received great interest because they exhibit enhanced optical and electromagnetic properties. Our fundamental studies of various plasmonic structures [8][9][10] and applied development of plasmonic nanoplatforms have led to a wide variety of applications ranging from chemical sensing [10][11][12] to cancer diagnostics [13][14][15][16][17] and therapy using nanoparticle-mediated photothermal treatment [15,[18][19][20]. Recently, we demonstrated that the use of plasmonic gold nanostars (GNS) in combination with immunotherapy -a treatment we referred to as Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) -can dramatically enhance the efficacy of immunotherapy. Remarkably, we have found that SYMPHONY not only eradicates primary 'treated' tumors but also has resulted in the immune-mediated destruction of distant 'untreated' metastatic tumors [21]. This abscopal effect occurred uniquely when nanoparticle-mediated photothermal heating of tumors was used in combination with immunotherapy.Plasmonic nanoparticles have unique properties that allow them to amplify the optical properties of the excitation light and thus increase the effectiveness of light-based photothermal tumor ablation. The unique properties which contribute to plasmonics-amplified immune nanotherapy for cancer, include: plasmonic nano-enhancers of light, nano-targeting of tumor cells, nanosources for heating tumor cells from the inside, nano-activators of the immune system and synergistic amplification of immunomodulation. These elements are discussed in the following sections.